会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 22. 发明申请
    • HLA binding peptides and their uses
    • HLA结合肽及其用途
    • US20090012004A1
    • 2009-01-08
    • US11882719
    • 2007-08-03
    • Alessandro SetteJohn SidneyScott SouthwoodEsteban Celis
    • Alessandro SetteJohn SidneyScott SouthwoodEsteban Celis
    • A61K38/00C07K7/00A61P37/00
    • A61K38/08A61K39/00A61K2039/55555C07K14/005C07K14/4748C07K14/70539C12N2730/10122C12N2770/24222
    • The present invention provides the means and methods for selecting immunogenic peptides and the immunogenic peptide compositions capable of specifically binding glycoproteins encoded by HLA alleles and inducing T cell activation in T cells restricted by the allele. The peptides are useful to elicit an immune response against a desired antigen. The immunogenic peptide compositions of the present invention comprise immunogenic peptides having an HLA binding motif, where the peptide is from a target antigen. Target antigens of the present invention include prostate specific antigen (PSA), hepatitis B core and surface antigens (HBVc, HBVs) hepatitis C antigens, Epstein-Barr virus antigens, melanoma antigens (e.g., MAGE-1), human immunodeficiency virus (HIV) antigens, human papilloma virus (HPV) antigens, Lassa virus, mycobacterium tuberculosis (MT), p53, CEA, trypanosome surface antigen (TSA) and Her2/neu.
    • 本发明提供了选择免疫原性肽的方法和方法以及能够特异性结合由HLA等位基因编码的糖蛋白并诱导由等位基因限制的T细胞中的T细胞活化的免疫原性肽组合物。 所述肽可用于引发针对所需抗原的免疫应答。 本发明的免疫原性肽组合物包含具有HLA结合基序的免疫原性肽,其中肽来自靶抗原。 本发明的靶抗原包括前列腺特异性抗原(PSA),乙型肝炎核心和表面抗原(HBVc,HBV)丙型肝炎抗原,爱泼斯坦 - 巴尔病毒抗原,黑素瘤抗原(例如MAGE-1),人类免疫缺陷病毒 )抗原,人乳头瘤病毒(HPV)抗原,拉沙病毒,结核分枝杆菌(MT),p53,CEA,锥虫表面抗原(TSA)和Her2 / neu。
    • 23. 发明授权
    • HLA binding peptides and their uses
    • HLA结合肽及其用途
    • US07252829B1
    • 2007-08-07
    • US09189702
    • 1998-11-10
    • Alessandro SetteJohn SidneyScott SouthwoodEsteban Celis
    • Alessandro SetteJohn SidneyScott SouthwoodEsteban Celis
    • A61K38/08A61K38/10A61K39/00C07K4/12
    • A61K38/08A61K39/00A61K2039/55555C07K14/005C07K14/4748C07K14/70539C12N2730/10122C12N2770/24222
    • The present invention provides the means and methods for selecting immunogenic peptides and the immunogenic peptide compositions capable of specifically binding glycoproteins encoded by HLA alleles and inducing T cell activation in T cells restricted by the allele. The peptides are useful to elicit an immune response against a desired antigen. The immunogenic peptide compositions of the present invention comprise immunogenic peptides having an HLA binding motif, where the peptide is from a target antigen. Target antigens of the present invention include prostate specific antigen (PSA), hepatitis B core and surface antigens (HBVc, HBVs) hepatitis C antigens, Epstein-Barr virus antigens, melanoma antigens (e.g., MAGE-1), human immunodeficiency virus (HIV) antigens, human papilloma virus (HPV) antigens, Lassa virus, mycobacterium tuberculosis (MT), p53, CEA, trypanosome surface antigen (TSA) and Her2/neu. An example of an immunogenic peptide of the present invention corresponds to a peptide less than about 15 amino acids in length that comprises an HLA-A2.1 binding motif, where the peptide comprises the p53 sequence SMPPPGTRV.
    • 本发明提供了选择免疫原性肽的方法和方法以及能够特异性结合由HLA等位基因编码的糖蛋白并诱导由等位基因限制的T细胞中的T细胞活化的免疫原性肽组合物。 所述肽可用于引发针对所需抗原的免疫应答。 本发明的免疫原性肽组合物包含具有HLA结合基序的免疫原性肽,其中肽来自靶抗原。 本发明的靶抗原包括前列腺特异性抗原(PSA),乙型肝炎核心和表面抗原(HBVc,HBV)丙型肝炎抗原,爱泼斯坦 - 巴尔病毒抗原,黑素瘤抗原(例如MAGE-1),人类免疫缺陷病毒 )抗原,人乳头瘤病毒(HPV)抗原,拉沙病毒,结核分枝杆菌(MT),p53,CEA,锥虫表面抗原(TSA)和Her2 / neu。 本发明的免疫原性肽的实例对应于包含HLA-A2.1结合基序的长度小于约15个氨基酸的肽,其中肽包含p53序列SMPPPGTRV。